Treatment: cognitive-behavioural

Sessions

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Alcohol — Treatment: cognitive-behavioural

Wednesday, 23 October

10:50

Stimulants — use, harm and interventions

10:50 to 12:20

Networking zone 4 (N4)

Janusz Sieroslawski

Definition of disorders

10:50 to 12:20

Networking zone 1 (N1)

Viktor Mravčík

15:00

Therapeutic horizons I

15:00 to 16:30

Networking zone 1 (N1)

Wouter Vanderplasschen

18:30

Workforce development and training

18:30 to 19:30

Networking zone 3 (N3)

Andrew Bennet

Smoking and health

18:30 to 19:30

Insights zone 1 (I1)

Robert West

Thursday, 24 October

13:20

Cannabis — risks and responses

13:20 to 14:50

Networking zone 4 (N4)

Jennifer Price

Focus on prescription drugs I

13:20 to 14:50

Insights zone 3 (I3)

Volker Auwärter

Policy and treatment

13:20 to 14:50

Insights zone 2 (I2)

Matthew Young

15:00

Treatment interventions

15:00 to 16:30

Networking zone 3 (N3)

Kari Grasaasen

Friday, 25 October

10:45

Findings from a feasibility trial and formative evaluation in England

The development and implementation of the ADVANCE intervention to reduce intimate partner violence perpetration by men in substance use treatment

10:45 to 12:15

Central square 3 (C3)

Gail Gilchrist

Treatment — improving standards and outcomes

10:45 to 12:15

Networking zone 3 (N3)

Gerhard Bühringer

Diversity in behavioural addictions

10:45 to 12:15

Networking zone 1 (N1)

Fernando Fernandez-Aranda

Therapeutic horizons II

10:45 to 12:15

Central square 1 (C1)

Felix Carvalho

Presentations

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Wednesday, 23 October

11:00

Short communication

Do more people in Europe need treatment for problems related to cocaine use? An analysis of cocaine treatment demand in nine European countries

11:00 to 11:10

Networking zone 4 (N4)

Antoine Jérôme

Oral presentation

Views about the disease and brain disease model of addiction: an international survey of addiction treatment providers in the USA, UK and Australia

11:00 to 11:15

Networking zone 1 (N1)

Anthony Barnett

11:10

Short communication

Psychostimulant induce neuronal plasticity by cytoskeleton remodeling via cdc42 pathway

11:10 to 11:20

Networking zone 4 (N4)

Andrea Lobo

11:15

Oral presentation

Reconsidering cannabis dependence

11:15 to 11:30

Networking zone 1 (N1)

Liz Temple

11:30

Oral presentation

Agreement degree with the content of the Substance Addiction Consequences Scale items - The development of a new instrument.

11:30 to 11:45

Networking zone 1 (N1)

Paulo Seabra

11:40

Short communication

Crackland in Brazil: epidemiological monitoring method and results

11:40 to 11:50

Networking zone 4 (N4)

Clarice Madruga

11:45

Oral presentation

Characterising people that demanded drug treatment in Catalonia: a cluster analysis

11:45 to 12:00

Networking zone 1 (N1)

Xavier Majó

11:50

Short communication

'I have no clue why I’m doing this' – a qualitative study on crack cocaine use in Frankfurt, Germany

11:50 to 12:00

Networking zone 4 (N4)

Bernd Werse

15:10

Oral presentation

A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous

15:10 to 15:25

Networking zone 1 (N1)

Raffaella Margherita Milani

15:25

Oral presentation

m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions

15:25 to 15:40

Networking zone 1 (N1)

Michael Schaub

15:40

Oral presentation

Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans

15:40 to 15:55

Networking zone 1 (N1)

Meryem Grabski

15:55

Oral presentation

The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019

15:55 to 16:10

Networking zone 1 (N1)

Adam Winstock

16:10

Oral presentation

Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial

16:10 to 16:25

Networking zone 1 (N1)

John Marsden

18:30

Short communication

The peer in outreach teams: a specialist among specialists?

18:30 to 18:40

Networking zone 3 (N3)

Maria João Oliveira

Oral presentation

Healthy recovery: results and reflections from a stepped wedge randomised controlled trial of a healthy lifestyle intervention within substance dependence treatment

18:40

The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace

18:40 to 18:50

Networking zone 3 (N3)

Camilla Lynne Bakkeng

18:45

Oral presentation

Clearing the smoke: vaping cannabis among adolescents. Recent trends and implications

18:50

Experiences of marketised welfare organisations among addiction treatment staff in Sweden

18:50 to 19:00

Networking zone 3 (N3)

Jessica Storbjörk

19:00

Short communication

Preparing effective addiction workforce: a challenge from the Czech perspective

19:00 to 19:10

Networking zone 3 (N3)

Amalie Pavlovská

Oral presentation

Tobacco harm reduction: key themes

19:10

Workforce development: the great paradox for the addictions sector

19:10 to 19:20

Networking zone 3 (N3)

Ann Roche

19:15

Oral presentation

A systematic review and network meta-analysis of the safety and effectiveness of smoking cessation medicines and electronic cigarettes

19:20

Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services

19:20 to 19:30

Networking zone 3 (N3)

Robert Calder

Thursday, 24 October

13:30

Short communication

Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CNR1 receptor and FAAH enzyme

13:30 to 13:40

Networking zone 4 (N4)

Chandni Hindocha

Oral presentation

Development of lower-risk gambling guidelines

The off-prescription use of modafinil: an online survey of perceived risks and benefits

13:40

Psychological aspects of cannabis use disorder: a review of the theory and implications for psychotherapy

13:40 to 13:50

Networking zone 4 (N4)

Daniel Feingold

13:45

Oral presentation

Couple treatment of pathological gambling: variables associated with better efficacy

Prospective cohort to assess the impact of removing non-prescription codeine in Australia

13:50

Intention to reduce cannabis use and help-seeking attitudes in Dutch frequent cannabis users.

13:50 to 14:00

Networking zone 4 (N4)

Marleen Olthof

14:00

Short communication

Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth.

14:00 to 14:10

Networking zone 4 (N4)

Cesar Leos-Toro

Oral presentation

Coping strategies and dysfunctional symptomatoly in pathological gamblers.

Characteristics and problematic opioid use in people prescribed opioids for CNCP over four years: a prospective cohort study

14:10

Cannabis use in early adulthood and later prescription of antipsychotics, mood stabilisers, antidepressants and anxiolytics.

14:10 to 14:20

Networking zone 4 (N4)

Eline Rognli

14:15

Oral presentation

A qualitative study of gabapentin use and misuse: perspectives of substance abuse treatment professionals

Determinants for the effectiveness of an Online Ambulatory Service for Internet Addicts (OASIS)

14:20

Have chronic cannabis consumers developed tolerance to the residual effects of recent cannabis use?

14:20 to 14:30

Networking zone 4 (N4)

Raimondo Bruno

14:30

Short communication

Sociodemographic and educational characteristics of cannabis users attending outpatient treatment centres: implications for psychoeducational intervention

14:30 to 14:40

Networking zone 4 (N4)

Samuel Rueda

14:40

Short communication

Can cannabis use cause death in humans ?

14:40 to 14:50

Networking zone 4 (N4)

Mateja Jandl

15:10

Short communication

Psychedelic-assisted psychotherapy for the treatment of addictions: The future of addiction treatment?

15:10 to 15:20

Networking zone 3 (N3)

Anton Gomez-Escolar

15:20

Short communication

Drug addiction in the immigrant population of users undergoing the low-threshold methadone maintenance programme in Lisbon

15:20 to 15:30

Networking zone 3 (N3)

Hugo Faria

15:30

Short communication

Employment influence in recovering people who use drugs during opiate substitution treatment

15:30 to 15:40

Networking zone 3 (N3)

Ângela Leite

15:40

Short communication

Working with complex families with parental substance abuse: an overview of the parents under pressure program

15:40 to 15:50

Networking zone 3 (N3)

Sharon Dawe

Friday, 25 October

10:45

Oral presentation

Food addiction and impaired executive functions in women with obesity

10:45 to 12:15

Networking zone 1 (N1)

Fernando Fernandez-Aranda

Oral presentation

Neural correlates of cue-reactivity and craving in individuals with buying-shopping disorder.

10:45 to 12:15

Networking zone 1 (N1)

Patrick Trotzke

Oral presentation

Are the practices of 'free-to-play' and 'pay-to-win' games new risk behaviours?

10:45 to 12:15

Networking zone 1 (N1)

Jean-Michel Costes

Oral presentation

‘Hooked on the mirror’: the emergence of a new cohort of gym users affected by exercise addiction, appearance anxiety and the use of fitness supplements

10:45 to 12:15

Networking zone 1 (N1)

Ornella Corazza

Oral presentation

The importance of a therapeutic contract in a CBT gambling disorder treatment

10:45 to 12:15

Networking zone 1 (N1)

Bruno Ricardo Neto Teixeira Bento

Oral presentation

The role of substance use in intimate partner abuse perpetration: rationale forthe ADVANCE programme of research

10:45 to 12:15

Central square 3 (C3)

Gail Gilchrist

Oral presentation

The dynamics of intimate partner abuse and drug and alcohol dependency: results from qualitative dyad interviews with male perpetrators of intimate partner abuse perpetration in substance use treatment and their current or ex female partners

10:45 to 12:15

Central square 3 (C3)

Juliet Henderson

Oral presentation

Development of an integrated intervention to reduce intimate partner abuse perpetration by men in substance use treatment: the ADVANCE intervention

10:45 to 12:15

Central square 3 (C3)

Gail Gilchrist

Oral presentation

Assessing the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment

10:45 to 12:15

Central square 3 (C3)

Gemma Halliwell

10:55

Short communication

Single-gender groups for women suffering from opioid use fisorder: theory and treatment

10:55 to 11:05

Networking zone 3 (N3)

Efrat Fridma

Oral presentation

Memory-focused cognitive therapy for cocaine use disorder: theory, procedures and preliminary evidence from an external pilot randomised controlled trial

10:55 to 11:10

Central square 1 (C1)

John Marsden

11:05

Short communication

Systematic monitoring and feedback on data results as supportive tools for substance use disorder individuals

11:05 to 11:15

Networking zone 3 (N3)

Thomas Solgård Svendsen

11:10

Oral presentation

Treatment of youth with substance use disorder and co-existing mental disorder: the MOVE programme.

11:10 to 11:25

Central square 1 (C1)

Mads Uffe Pedersen

11:15

Short communication

Patient-centered care for addictions treatment: findings from a scoping review

11:15 to 11:25

Networking zone 3 (N3)

Kirsten Marchand

11:25

Short communication

OST futures: integrating the user’s experience into person-centred care

11:25 to 11:35

Networking zone 3 (N3)

Karen Black

Oral presentation

The impact of maternal alexithymia on parenting behaviours in the context of substance use disorders

11:25 to 11:40

Central square 1 (C1)

Alessio Porreca

11:35

Short communication

Telephone delivered incentives for encouraging adherence to supervised methadone (TIES): development and feasibility study

11:35 to 11:45

Networking zone 3 (N3)

Nicola Metrebian

11:40

Oral presentation

The role of social environment in pathways to recovery: a scoping review

11:40 to 11:55

Central square 1 (C1)

João Pedro Ramos

11:45

Short communication

Benzodiazepine use in an opioide maintenance programme: risks and clinical outcomes

11:45 to 11:55

Networking zone 3 (N3)

Catarina Oliveira

11:55

Short communication

Telephone-delivered contingency management to promote behaviour change in addiction treatment.

11:55 to 12:05

Networking zone 3 (N3)

Carol-Ann Getty

12:05

Short communication

Measuring personality problems in patients with substance use disorders

12:05 to 12:15

Networking zone 3 (N3)

Espen Ajo Arnevik